<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04710446</url>
  </required_header>
  <id_info>
    <org_study_id>Normal MI</org_study_id>
    <nct_id>NCT04710446</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics, Treatments, and Outcomes of MI Patients Presenting With Normal ECG</brief_title>
  <official_title>Clinical Characteristics, Treatments, and Outcomes of MI Patients Presenting With Normal ECG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henan Provincial People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigators aimed to analyzed data for hospitalized MI patients with normal ECG.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The electrocardiogram (ECG) at presentation is a useful tool for risk prediction. Patients&#xD;
      with ACS（Acute Coronary Syndromes） and ST-segment depression on ECG have a worse prognosis&#xD;
      than patients with a normal ECG. ST-segment depression is not only a qualitative marker, but&#xD;
      also a quantitative marker of risk, because the number of leads with ST-segment depression&#xD;
      and the magnitude of ST-segment depression (either within a single lead or as sum over all&#xD;
      leads) are indicative of the extent of ischaemia and correlate with prognosis.The presence of&#xD;
      ST-segment depression &gt;1 mm in &gt;_6 leads in conjunction with ST-segment elevation in aVR&#xD;
      and/or V1, particularly if the patient presents with haemodynamic compromise, suggests&#xD;
      multivessel ischaemia or severe left main coronary artery stenosis. However,in patients&#xD;
      presenting without persistent ST-segment elevation,the clinical features, treatments, and&#xD;
      outcomes in patients with normal ECG is still unclear.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>MACE within 2 weeks</measure>
    <time_frame>within 2 weeks</time_frame>
    <description>Major Adverse Cardiovascular Events within2 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACE within 1 year</measure>
    <time_frame>within 1 year</time_frame>
    <description>Major Adverse Cardiovascular Events in-hospital within 1 year</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Non-ST Elevated Myocardial Infarction</condition>
  <condition>Electrocardiography</condition>
  <arm_group>
    <arm_group_label>NSTEMI Patients presenting with normal ECG</arm_group_label>
    <description>NSTEMI Patients presenting with normal ECG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NSTEMI Patients presenting with isolated T wave inversion</arm_group_label>
    <description>NSTEMI Patients presenting with isolated T wave inversion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NSTEMI Patients presenting with transient ST-segment elevation</arm_group_label>
    <description>NSTEMI Patients presenting with transient ST-segment elevation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NSTEMI Patients presenting with resting U wave inversion</arm_group_label>
    <description>NSTEMI Patients presenting with resting U wave inversion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NSTEMI Patients presenting with low QRS voltage</arm_group_label>
    <description>NSTEMI Patients presenting with low QRS voltage</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        NSTEMI Patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:all patients hospitalized with a principal diagnosis of non-ST-segment&#xD;
        elevation infarction (NSTEMI) according to the current ACC/AHA guidelines.&#xD;
&#xD;
        exclusion criteria: end-stage organic disease, thrombotic hematological disorders, and poor&#xD;
        echogenicity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yansheng Huang</last_name>
    <role>Study Director</role>
    <affiliation>Henan Province People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>qiongya Guo</last_name>
    <phone>18838067197</phone>
    <email>gqy19870203@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>minghu Zhao</last_name>
    <phone>13603996609</phone>
    <email>634851967@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henan province people's hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yansheng Huang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 2, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Clinical Characteristics</keyword>
  <keyword>Treatments</keyword>
  <keyword>Outcomes</keyword>
  <keyword>normal ECG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

